News releases - Merck.com
WEB5 days ago · FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) September 17, 2024.
Merck Provides Update on FDA’s Oncologic Drugs Advisory …
WEB3 days ago · RAHWAY, N.J., Sept. 26, 2024 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the outcomes of today’s U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting. The meeting was convened to discuss the risk-benefit assessment of the use of immune checkpoint inhibitors, including KEYTRUDA® (pembrolizumab), […]
Merck to Present New Long-Term Data for Tulisokibart (MK-7240), …
WEB4 days ago · This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject ...
News & Stories - Merck
WEBSep 16, 2024 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
FDA approves Merck's drug for rare, deadly lung condition
WEBMar 26, 2024 · The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients...
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
WEBMar 26, 2024 · Merck MRK 0.53% is making a big bet that its new drug, approved Tuesday in the U.S. for a potentially fatal lung disease, will take the company a long way toward heading off a massive revenue ...
Merck (MRK) earnings Q2 2024 - CNBC
WEBJul 30, 2024 · Merck on Tuesday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations as it saw strong sales from its blockbuster cancer drug Keytruda as well as other...
Merck Launches First Ever AI Solution to Integrate Drug Discovery …
WEBDec 5, 2023 · Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule ...
Merck’s Covid Pill Is Authorized for High-Risk Adults - The New …
WEBDec 23, 2021 · Merck is expected to fulfill the federal government’s full order of enough pills for 3.1 million people, at a cost of about $700 a person, by the end of January. Pfizer is expected to provide...
Merck’s KEYTRUDA - Business Wire
WEB5 days ago · Merck’s KEYTRUDA Receives New Approvals in Japan for Certain Patients With NSCLC and Radically Unresectable Urothelial Carcinoma ... N.J., USA This news release of Merck & Co., Inc., Rahway, N.J ...